Everest Medicines is a biopharmaceutical company based in Hong Kong. As a leader in the industry, they specialize in the development, manufacturing, and commercialization of innovative pharmaceutical products and vaccines. Their primary focus is on addressing critical unmet medical needs for patients in China and other Asian Pacific markets.

With a highly experienced management team, Everest Medicines boasts a strong track record in discovery, clinical development, regulatory affairs, business development, and commercialization. This expertise extends to both the Chinese market and global pharmaceutical companies. Everest Medicines has curated an impressive portfolio of potentially groundbreaking molecules in the areas of renal diseases, infectious diseases, and autoimmune disorders.

They recently began their commercial operations and are actively building a skilled and efficient commercial team to serve Greater China and other Asia-Pacific markets. Additionally, Everest Medicines has established a robust drug discovery and research team to drive independent research and development. They leverage their expertise in disease biology and cutting-edge technologies, such as the clinically validated mRNA platform.

To stay updated on their approved products and ongoing therapeutic candidates, visit their website. Connect with Everest Medicines on WeChat to access even more information and updates